Skip to main content
Clinical Trials/NCT00985361
NCT00985361CompletedNot Applicable

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

ProMedica Health System6 sites in 1 country37 target enrollmentStarted: October 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
37
Locations
6
Primary Endpoint
Hemoglobin A1c

Study Overview

Brief Summary

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Detailed Description

Vitamin D is typically understood to support musculoskeletal health when administered concomitantly with calcium. A number of recent studies suggest, however, that this important nutrient may play a significant role in many pathophysiological processes, including diabetes mellitus. With the prevalence of diabetes mellitus ever increasing, novel mechanisms for controlling blood glucose and hemoglobin A1c are being sought to help prevent the costly and debilitating complications of this chronic disease.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
21 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Type 2 diabetes mellitus
  • Hemoglobin A1c >7% measured in the 3 months prior to randomization
  • Age 21 to 75 years

Exclusion Criteria

  • Renal insufficiency (defined as CrCl <30mL/min)
  • Gestational diabetes
  • Malabsorption syndrome
  • Patients taking vitamin D supplements at doses >400 international units daily

Outcomes

Primary Outcomes

Hemoglobin A1c

Time Frame: 3 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
ProMedica Health System
Sponsor Class
Other

Study Sites (6)

Loading locations...

Similar Trials